Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China flag China · Delayed Price · Currency is CNY
5.97
+0.09 (1.53%)
Apr 29, 2026, 4:00 PM EDT

SHA:688373 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
307.95316.1386.26166.31151.09145.52
Trading Asset Securities
112.91135.54207.36786.981,119326.36
Cash & Short-Term Investments
420.86451.64593.62953.31,270471.88
Cash Growth
-29.92%-23.92%-37.73%-24.95%169.17%-25.92%
Accounts Receivable
39.6537.9631.8821.9811.11.42
Other Receivables
20.2120.5221.020.190.340
Receivables
59.8658.4752.922.1711.441.42
Inventory
44.450.2552.9437.5221.8911.01
Other Current Assets
70.6262.0949.2141.2767.0125.29
Total Current Assets
595.74622.46748.661,0541,371509.59
Property, Plant & Equipment
61.8661.7375.886.2197.46122.8
Other Intangible Assets
0.810.951.681.932.190.84
Long-Term Deferred Charges
15.2816.0419.121.7522.681.83
Other Long-Term Assets
3.913.913.894.424.5413.48
Total Assets
677.59705.09849.131,1691,497648.54
Accounts Payable
73.4216.5726.2111.1310.851.91
Accrued Expenses
2.7296.5178.6394.5137.4129.45
Short-Term Debt
25.0225.025-48.7550.08
Current Portion of Long-Term Debt
140.0668.4289.2314.1510.1-
Current Portion of Leases
-12.7711.5110.386.4711.04
Current Income Taxes Payable
20.160.2-4.41--
Current Unearned Revenue
5.190.47-0.13--
Other Current Liabilities
21.464.421.711.931.521.71
Total Current Liabilities
288.02224.38212.3136.65115.1194.19
Long-Term Debt
139.44213.04122.94114.9670-
Long-Term Leases
66.4560.3873.1881.794.8999.87
Long-Term Unearned Revenue
1.751.751.751.253.116.1
Total Liabilities
495.66499.55410.16334.56283.1210.17
Common Stock
656.23656.23655.61655.21655.21525.21
Additional Paid-In Capital
1,5881,5881,5711,5321,495636.77
Retained Earnings
-2,068-2,046-1,805-1,364-942.85-722.55
Comprehensive Income & Other
5.277.6917.0810.917.19-1.06
Shareholders' Equity
181.94205.54438.968341,214438.37
Total Liabilities & Equity
677.59705.09849.131,1691,497648.54
Total Debt
370.97379.62301.86221.19230.21160.99
Net Cash (Debt)
49.972.02291.76732.111,040310.88
Net Cash Growth
-79.44%-75.32%-60.15%-29.60%234.52%-50.69%
Net Cash Per Share
0.080.110.441.121.790.59
Filing Date Shares Outstanding
715.12655.61655.61655.21655.21525.21
Total Common Shares Outstanding
715.12655.61655.61655.21655.21525.21
Working Capital
307.72398.08536.37917.611,255415.39
Book Value Per Share
0.250.310.671.271.850.83
Tangible Book Value
181.13204.59437.28832.071,212437.53
Tangible Book Value Per Share
0.250.310.671.271.850.83
Machinery
-14.814.4114.1811.756.01
Construction In Progress
-----15.65
Source: S&P Global Market Intelligence. Standard template. Financial Sources.